Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

73 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
CHA2DS2-VASc Score as an Independent Predictor of Suboptimal Reperfusion and Short-Term Mortality after Primary PCI in Patients with Acute ST Segment Elevation Myocardial Infarction.
Ashoori A, Pourhosseini H, Ghodsi S, Salarifar M, Nematipour E, Alidoosti M, Haji-Zeinali AM, Nozari Y, Amirzadegan A, Aghajani H, Jalali A, Hosseini Z, Jenab Y, Geraiely B, Omidi N. Ashoori A, et al. Among authors: aghajani h. Medicina (Kaunas). 2019 Feb 1;55(2):35. doi: 10.3390/medicina55020035. Medicina (Kaunas). 2019. PMID: 30717292 Free PMC article.
Impact of side-branch flow in coronary bifurcation intervention.
Poorhosseini HR, Kassaian SE, Hosseini SK, Fotoohi M, Salarifar M, Alidoosti M, Sharafi A, Nozari Y, Nematipour E, Aghajani H, Haji Zeinali AM, Amirzadegan A, Babapour B, Seyed Mohammad Zadeh MH. Poorhosseini HR, et al. Among authors: aghajani h. J Tehran Heart Cent. 2012 Aug;7(3):100-5. Epub 2012 Aug 31. J Tehran Heart Cent. 2012. PMID: 23304177 Free PMC article.
Effect of Early Treatment With Tirofiban on Initial TIMI Grade 3 Flow of Patients With ST Elevation Myocardial Infarction.
Salarifar M, Mousavi M, Yousefpour N, Nematipour E, Kassaian SE, Poorhosseini H, Hajizeinali A, Alidoosti M, Aghajani H, Nozari Y, Amirzadegan A, Bozorgi A, Genab Y. Salarifar M, et al. Among authors: aghajani h. Iran Red Crescent Med J. 2014 Jan;16(1):e9641. doi: 10.5812/ircmj.9641. Epub 2014 Jan 5. Iran Red Crescent Med J. 2014. PMID: 24719720 Free PMC article.
Opium consumption and mid-term outcome of percutaneous coronary intervention in men.
Sharafi A, Pour Hosseini HR, Jalali A, Salarifar M, Nematipour E, Shojanasab M, Aghajani H, Amirzadegan A, Nozari Y, Alidoosti M, Zeinali AH, Kassaian SE. Sharafi A, et al. Among authors: aghajani h. J Tehran Heart Cent. 2014;9(3):115-9. Epub 2014 Jul 3. J Tehran Heart Cent. 2014. PMID: 25870628 Free PMC article.
Comparing clinical outcomes for a twelve-month trial of zotarolimus- and everolimus-eluting stents in patients with coronary artery disease: data from the THCRIC registry.
Poorhoseini HR, Kassaian SE, Hoseini K, Saroukhani S, Salarifar M, Alidoosti M, Nematipour E, Haji-Zeinali AM, Amirzadegan A, Seyyed Mohammadzadeh MH, Khadem Vatan K, Aghajani H, Sheikh Fathollahi M, Farrokh-Eslamlou H. Poorhoseini HR, et al. Among authors: aghajani h. Ther Adv Cardiovasc Dis. 2016 Aug;10(4):206-13. doi: 10.1177/1753944716629868. Epub 2016 Feb 7. Ther Adv Cardiovasc Dis. 2016. PMID: 26857928 Free PMC article.
A Risk-Scoring Model to Predict One-year Major Adverse Cardiac Events after Percutaneous Coronary Intervention.
Kassaian SE, Saroukhani S, Alaeddini F, Salarifar M, Capodanno D, Poorhoseini H, Lotfi-Tokaldany M, Leesar MA, Aghajani H, Hakki-Kazzazi E, Alidoosti M, Haji-Zeinali AM, Saifi M, Nematipour E. Kassaian SE, et al. Among authors: aghajani h. J Tehran Heart Cent. 2015 Oct 27;10(4):167-75. J Tehran Heart Cent. 2015. PMID: 26985204 Free PMC article.
Biodegradable-Polymer Biolimus-Eluting Stents versus Durable-Polymer Everolimus-Eluting Stents at One-Year Follow-Up: A Registry-Based Cohort Study.
Parsa E, Saroukhani S, Majlessi F, Poorhosseini H, Lofti-Tokaldany M, Jalali A, Salarifar M, Nematipour E, Alidoosti M, Aghajani H, Amirzadegan A, Kassaian SE. Parsa E, et al. Among authors: aghajani h. Tex Heart Inst J. 2016 Apr 1;43(2):126-30. doi: 10.14503/THIJ-14-4997. eCollection 2016 Apr. Tex Heart Inst J. 2016. PMID: 27127426 Free PMC article.
Comparison of 1-year Major Adverse Cardiac Events in Patients Undergoing Primary Percutaneous Coronary Intervention Receiving Intracoronary Bolus Only Versus Intracoronary Bolus Plus Infusion of Glycoprotein IIb/IIIa Inhibitors.
Kassaian SE, Fathi Y, Lotfi-Tokaldany M, Salarifar M, Alidoosti M, Haji-Zeinali AM, Aghajani H, Amirzadegan A, Nozari Y, Mortazavi SH, Jalali A, Saroukhani S. Kassaian SE, et al. Among authors: aghajani h. Crit Pathw Cardiol. 2016 Sep;15(3):89-94. doi: 10.1097/HPC.0000000000000079. Crit Pathw Cardiol. 2016. PMID: 27465002
73 results